In acute PD mice, Se-Met at either low or high doses could not influence much the mRNA levels of GPX1 and GPX4, but treatment with a high dosage of Se-Met significantly downregulated Sepp1 mRNA levels (p < 0.05 vs. Model). This evidence concerns the gene GPX4 and Parkinson disease.